A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A “Smart” Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases
Open Access
- 1 November 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (21) , 6335-6343
- https://doi.org/10.1158/1078-0432.ccr-07-1004
Abstract
Purpose: Fluorophore activation after cellular internalization of a targeted fluorescently labeled conjugate is an effective molecular imaging strategy to increase target-to-background ratios. The d-galactose receptor on ovarian cancer cells has been used to target self-quenched avidin-rhodamineX conjugates in which the avidin component binds to d-galactose receptor and the rhodamines are optically activated by dequenching only after cellular internalization. As a nonimmunogenic alternative of avidin, galactosamine-conjugated serum albumin (GmSA) targets the d-galactose receptor with higher binding affinity and has more conjugation sites available for rhodamineX than avidin. Experimental Design: GmSA was conjugated with 20 rhodamineX molecules (GmSA-20ROX) to create a self-quenching complex, which was compared with a conjugate consisting of GmSA and a single rhodamineX (GmSA-1ROX) in ex vivo chemical activation characteristics, intracellular activation, and in vivo molecular imaging for detecting peritoneal micrometastases of SHIN3 ovarian cancer. Results: GmSA-20ROX was five times brighter than GmSA-1ROX when incubated with SHIN3 ovarian cancer cells for 3 h. Submillimeter SHIN3 ovarian cancer implants in the peritoneal cavity were clearly visualized in vivo with spectral fluorescence imaging due to the high tumor-to-background ratio. The sensitivity and specificity of GmSA-20ROX for implant detection were determined by colocalization of the rhodamineX emission with red fluorescent protein expressed constitutively in the SHIN3 tumor implants. Among 336 lesions, sensitivity and specificity were 99%/99%, respectively, for GmSA-20ROX, whereas the results for GmSA-1ROX were only 24%/100% (n = 388), respectively, for lesions ∼0.8 mm or greater in diameter. Conclusion: Self-quenched GmSA-20ROX is more efficient than previous d-galactose–targeted fluorescent conjugates.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- An Enzymatically Activated Fluorescence Probe for Targeted Tumor ImagingJournal of the American Chemical Society, 2007
- D-galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamin-conjugated serum albumin-rhodamine greenJournal of Biomedical Optics, 2007
- A Comparison of the Emission Efficiency of Four Common Green Fluorescence Dyes after Internalization into Cancer CellsBioconjugate Chemistry, 2006
- Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidinBiochemical and Biophysical Research Communications, 2006
- In Vivo Spectral Fluorescence Imaging of Submillimeter Peritoneal Cancer Implants Using a Lectin-Targeted Optical AgentNeoplasia, 2006
- A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular ImagingCell, 2006
- Adventures in multivalency, the Harry S. Fischer memorial lecture CMR 2005; Evian, FranceContrast Media & Molecular Imaging, 2006
- Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatmentBiochemical Journal, 2003
- The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Establishment and Characterization of a Human Ovarian Serous Cystadenocarcinoma Cell Line That Produces the Tumor Markers CA-125 and Tissue Polypeptide AntigenOncology, 1990